Trials / Unknown
UnknownNCT03633890
DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris
A Randomized, Double-Blind, Placebo-Controlled Trial for DaZhu Rhodiola Rosea Capsule in the Treatment of Coronary Artery Disease With Angina Pectoris
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 102 (estimated)
- Sponsor
- Beijing Anzhen Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the efficacy and safety of traditional Chinese medicine DaZhu Rhodiola Rosea Capsule for treatment of coronary artery disease by observing angina symptoms, exercise capacity, and quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DaZhu Rhodiola Rosea Capsule | Oral administration, 4 capsules, 3 times a day, for 8 weeks |
| DRUG | DaZhu Rhodiola Rosea Simulation Capsule | Oral administration, 4 capsules, 3 times a day, for 8 weeks |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2019-02-01
- Completion
- 2019-02-01
- First posted
- 2018-08-16
- Last updated
- 2018-08-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03633890. Inclusion in this directory is not an endorsement.